Status:
COMPLETED
Lymphangioleiomyomatosis, a Study on Cathepsin K
Lead Sponsor:
University Hospital, Tours
Conditions:
Lymphangioleiomyomatosis
Tuberous Sclerosis Complex
Eligibility:
FEMALE
18+ years
Brief Summary
This is a physiopathological case-control, non-interventional, monocentric study of adult patients with lymphangioleiomyomatosis. The controls are patients followed in neurology at the CHU of Tours fo...
Eligibility Criteria
Inclusion
- Inclusion criteria for patients with lymphangioleiomyomatosis
- Age ≥ 18 years
- Female carrier of lymphangioleiomyomatosis according to ERS criteria
- Inclusion criteria for healthy female volunteers
- Age ≥ 18 years
- Women with no history of lymphangioleiomyomatosis, pulmonary, renal or osteoporotic disease
- Inclusion criteria for tuberous sclerosis complex patients without lymphangioleiomyomatosis
- Age ≥ 18 years
- Woman followed for tuberous sclerosis complex for whom a chest CT scan less than 3 years old does not objectify a pulmonary cyst. (= without lymphangioleiomyomatosis)
- Non-inclusion criteria
- Woman under judicial protection
- Woman with a urinary tract infection within 15 days
- Person who objected to the data processing
Exclusion
Key Trial Info
Start Date :
May 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2022
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT05323370
Start Date
May 31 2022
End Date
October 30 2022
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University hospital
Tours, France, 37044